Tuesday, February 10, 2026
ADVT 
International

US offers more monkeypox vaccine to states and cities

Darpan News Desk The Canadian Press, 15 Aug, 2022 02:19 PM
  • US offers more monkeypox vaccine to states and cities

NEW YORK (AP) — U.S. officials said they are able to ship out more monkeypox vaccine doses than previously planned — because of a strategy shift that allows more shots to be drawn from each vial.

The U.S. Department of Health and Human Services had previously anticipated allowing 221,000 doses to be ordered starting Monday. But officials said they would release 442,000 doses for order by state, local and territorial health departments.

The accelerated release was only possible because U.S. health officials said last week that they would stretch the nation’s limited supply of Jynneos monkeypox vaccine by giving people one-fifth the usual dose, injected just under the skin. Previously, each vaccine dose required a full vial injected into deeper tissue. They cited research suggesting that the reduced amount is about as effective.

The 442,000 doses would equate to about 88,000 vials.

Officials said the new approach allows them to make hundreds of thousands more doses available now while they gather data about how the shots are being used. That will help the government make sure doses are being administered to the places and people that need them most, officials said.

U.S. officials previously shipped more than 630,000 doses, though not all have been used.

Federal health officials have suggested they would need about 3.2 million shots to vaccinate all those considered at highest risk of monkeypox.

MORE International ARTICLES

UK advises limiting AstraZeneca in under-30s amid clot worry

UK advises limiting AstraZeneca in under-30s amid clot worry
While the benefits of the vaccine still outweigh the risks, that assessment is “more finely balanced" among younger people who are less likely to become seriously ill with COVID-19

UK advises limiting AstraZeneca in under-30s amid clot worry

COVID vaccine found highly effective in real-world US study

COVID vaccine found highly effective in real-world US study
The two vaccines available since December — Pfizer and Moderna — were 90% effective after two doses, the Centers for Disease Control and Prevention reported Monday. In testing, the vaccines were about 95% effective in preventing COVID-19.

COVID vaccine found highly effective in real-world US study

Reputation of AstraZeneca's COVID vaccine marred by missteps

Reputation of AstraZeneca's COVID vaccine marred by missteps
In Norway, a top official warned on Monday it might not be able to resume its use of the vaccine because so many people were rejecting it.

Reputation of AstraZeneca's COVID vaccine marred by missteps

EXPLAINER: Will you need a 'vaccine passport' to travel?

EXPLAINER: Will you need a 'vaccine passport' to travel?
It is not clear, however, whether any of the passports under development will be accepted broadly around the world, and the result could be confusion among travellers and disappointment for the travel industry.

EXPLAINER: Will you need a 'vaccine passport' to travel?

EXPLAINER: Why Georgia attack spurs fears in Asian Americans

EXPLAINER: Why Georgia attack spurs fears in Asian Americans
As details emerge, many members of the Asian American community see the Georgia killings as a haunting reminder of harassment and assaults that have been occurring from coast to coast.

EXPLAINER: Why Georgia attack spurs fears in Asian Americans

EXPLAINER: Why countries are halting the AstraZeneca shot

EXPLAINER: Why countries are halting the AstraZeneca shot
Norway, Iceland, Bulgaria, Thailand, and Congo soon followed suit. On Saturday, Norwegian authorities reported that four people under age 50 who had gotten the AstraZeneca vaccine had an unusually low number of blood platelets.

EXPLAINER: Why countries are halting the AstraZeneca shot